GRI Bio receives Nasdaq deficiency notice for minimum bid price non-compliance

GRI Bio, Inc.

Received Nasdaq letter on Sept 10, 2024; closing bid price below $1.00 for 30 consecutive business days.
Has 180 calendar days (until March 10, 2025) to regain compliance by closing at $1.00 for 10 consecutive business days.
If stock closes at $0.10 or less for 10 consecutive days before compliance date, Nasdaq will issue delisting determination.
Company monitoring options to regain compliance; no assurance of success.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.